- Home
- ACI vs PCVX Comparison
ACI vs PCVX Comparison
Compare ACI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACI
- PCVX
- Stock Information
- Founded
- ACI 1860
- PCVX 2013
- Country
- ACI United States
- PCVX United States
- Employees
- ACI N/A
- PCVX N/A
- Industry
- ACI Food Chains
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ACI Consumer Staples
- PCVX Health Care
- Exchange
- ACI Nasdaq
- PCVX Nasdaq
- Market Cap
- ACI 11.0B
- PCVX 13.2B
- IPO Year
- ACI 2020
- PCVX 2020
- Fundamental
- Price
- ACI $19.37
- PCVX $88.54
- Analyst Decision
- ACI Buy
- PCVX Strong Buy
- Analyst Count
- ACI 9
- PCVX 7
- Target Price
- ACI $23.94
- PCVX $147.50
- AVG Volume (30 Days)
- ACI 2.9M
- PCVX 1.6M
- Earning Date
- ACI 01-07-2025
- PCVX 11-05-2024
- Dividend Yield
- ACI 2.48%
- PCVX N/A
- EPS Growth
- ACI N/A
- PCVX N/A
- EPS
- ACI 1.71
- PCVX N/A
- Revenue
- ACI $79,713,700,000.00
- PCVX N/A
- Revenue This Year
- ACI $2.49
- PCVX N/A
- Revenue Next Year
- ACI $2.03
- PCVX N/A
- P/E Ratio
- ACI $11.33
- PCVX N/A
- Revenue Growth
- ACI 1.21
- PCVX N/A
- 52 Week Low
- ACI $17.80
- PCVX $48.24
- 52 Week High
- ACI $23.47
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- ACI 58.25
- PCVX 29.48
- Support Level
- ACI $18.96
- PCVX $85.18
- Resistance Level
- ACI $19.44
- PCVX $92.87
- Average True Range (ATR)
- ACI 0.38
- PCVX 5.42
- MACD
- ACI 0.03
- PCVX -1.35
- Stochastic Oscillator
- ACI 81.59
- PCVX 12.77
About ACI Albertsons Companies Inc.
Albertsons is the second largest supermarket operator in the United States with over 2,200 stores across a variety of banners. About 80% of the firm's sales stem from non-perishable and fresh food, of which 25% comes from its portfolio of private brands. The company operates fuel centers and pharmacies at about 20% and 75% of its store locations, respectively. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of outstanding shares.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.